Recent Articles from this contributor
U.S. Healthcare Stocks and the U.S. Presidential Election
AGF Investments Inc. analyst Ling Han discusses the potential election impact to managed care stocks and other segments of the…
An Investor’s Guide to GLP-1 Drugs: Beyond Biopharma Stocks
In part one of a series, analyst Ling Han discusses the potential impact of GLP-1 drugs to healthcare stocks not directly involved in the development and manufacture of the medical world’s latest pharmaceutical phenomenon
GLP-1: Healthcare’s Latest Investment Mega Theme
AGF analyst Ling Han discusses the pharmaceutical drug front and center with healthcare investors.